S'abonner

An alternative workflow for drug analysis - 15/08/22

Doi : 10.1016/j.toxac.2022.06.242 
Nayan Mistry , Emily Lee, Michelle Wood
 Forensic toxicology, Waters ltd, Wilmslow, United Kingdom 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Aim

The increase in number, diversity and potential toxicity of drugs is a major concern; it also presents significant challenges for forensic laboratories who are involved in the analysis of seized substances and need to turnaround results quickly. Consequently, analytical methods that can provide fast, reliable results are of interest. Traditional analytical workflows include colorimetric, or TLC screening followed by confirmatory analysis using more selective methods e.g., GC-MS. The aim of this study was to assess the potential of an alternative workflow comprising a rapid screen based on Atmospheric Solids Analysis Probe-Mass Mass Spectrometry (ASAP-MS), followed by confirmation using UPLC-Time of Flight-MS (UPLC-ToF-MS).

Method

Certified reference material (CRM), pharmaceuticals and seized materials were analysed using the RADIAN-ASAP (Waters) – a compact, direct analysis device combining ASAP with MS. Seized samples (tablets, pills, powders) were prepared by dilution with methanol. A glass capillary was dipped into each sample before being inserted into the instrument. The system was operated in full scan MS mode and data collected at four cone voltages (15, 25, 35, 50V). Data were processed in real-time and compared to a spectral library prepared using the same conditions. A match score of 850 (from a maximum 1000) was applied as the threshold for a positive identification. Analysis time was ∼30sec.

The same samples were analysed by UPLC-ToF-MS, following further dilution. The confirmation method comprised a UPLC I-Class coupled with an ACQUITY RDa detector (Waters). Chromatographic separation was achieved in 9.5min and accurate mass data was acquired in full scan (positive ionization with fragmentation). Resultant data were compared with a library comprising>100 drug substances. Identification was based on retention time (±0.35min of reference retention time), detection of a precursor mass, and the presence of at least one diagnostic fragment ion.

Results

The ASAP ionization process was demonstrated to be similar to atmospheric pressure chemical ionization, whereby a heated desolvation gas is used to volatilize the sample and a corona discharge to ionize. This resulted in the protonated species for most of the drugs analysed in this study. Application of increasing cone voltages resulted in a spectral fingerprint for each drug, comprising precursor and fragment ions. In the absence of chromatographic separation, this provided increased specificity.

The performance of the rapid ASAP-MS screen was initially evaluated by analysis of CRM (67 samples). For identified substances, match scores were all>870; sensitivity and specificity of the technique were both>95%.

Pharmaceutical preparations (10) and seized material (80) were analysed by ASAP-MS and UPLC-Tof-MS (blinded analysis, two independent scientists). Overall, there was excellent qualitative agreement with concordance for>90% of the drugs detected. Where discrepancies were observed, this was owing to differences in the content of the respective reference libraries, or a difference in the sensitivity of detection (4 samples gave match scores below the minimum threshold applied for the rapid screen). Two of the pharmaceutical preparations did not yield any match with either analytical technique but gave a visible peak by UPLC-Tof-MS. The data was submitted to the structural elucidation tools of the software which returned a proposal. This was subsequently confirmed following analysis of CRM.

Conclusion

ASAP-MS is a rapid, yet accurate and easy-to-use screen. It can identify single, or multiple components, in seized materials and shows potential for a rapid triage of samples to improve laboratory workflow. The UPLC-ToF-MS method used as the reference technique for these studies has also been demonstrated to be a powerful complementary (or standalone) technique, offering confirmation of identity through accurate mass together with the potential to identify unknown substances through structural elucidation.

Le texte complet de cet article est disponible en PDF.

Plan


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 34 - N° 3S

P. S144-S145 - septembre 2022 Retour au numéro
Article précédent Article précédent
  • Qualitative and quantitative evaluation of the physiologically active substances in commercially available Withania somnifera supplements
  • Amarnath Mishra, Akanksha Behl
| Article suivant Article suivant
  • Ethanol and putrefaction: Medicolegal relevance of the study of different biological samples
  • Carla Monteiro, Maria Castilho, Francisco Corte Real, Paula Proença

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.